Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT)

B Aksu, T De Beer, S Folestad, J Ketolainen… - European Journal of …, 2012 - Elsevier
Substantial changes in Pharmaceutical R&D strategy are required to address existing issues
of low productivity, imminent patent expirations and pressures on pricing. Moves towards …
被引用次数：79 相关文章
[PDF] academia.edu

[PDF][PDF] Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT)

B Aksu, T De Beer, S Folestad, J Ketolainen… - European Journal of …, 2012 - academia.edu
abstract Substantial changes in Pharmaceutical R&D strategy are required to address
existing issues of low productivity, imminent patent expirations and pressures on pricing …

[引用][C] Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT)

European Journal of Pharmaceutical Sciences, 2012 - sustainablefutures.ku.dk
Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD)
and Process Analytical Technology (PAT) - Cattle Crossroads - Researching Danish livestock …

[引用][C] Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT)

European Journal of Pharmaceutical Sciences, 2012 - drug.ku.dk
Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD)
and Process Analytical Technology (PAT) - Staff Topic navigation Content Footer links Start …

[引用][C] Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT)

European Journal of Pharmaceutical Sciences, 2012 - psy.ku.dk
Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD)
and Process Analytical Technology (PAT) - Videnskabeligt personale Emnenavigation …

[引用][C] Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT) Publikation: Bidrag til …

plen.ku.dk
Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD)
and Process Analytical Technology (PAT) - Biochemical Engineering Emnenavigation …

[引用][C] Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT) Publikation: Bidrag til …

kunstogkulturvidenskab.ku.dk
Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD)
and Process Analytical Technology (PAT) - Kulturkritik i det 21. århundrede Emnenavigation …

[引用][C] Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT) Publikation: Bidrag til …

saxo.ku.dk
Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD)
and Process Analytical Technology (PAT) - Ph.d. Emnenavigation Indhold Footerlinks Start …

[引用][C] Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT)

European Journal of Pharmaceutical Sciences, 2012 - di.ku.dk
Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and
Process Analytical Technology (PAT) - Staff Topic navigation Content Footer links Start Toggle …

[引用][C] Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT)

B Aksu, T De Beer, S Folestad, J Ketolainen… - European Journal of …, 2012 - cir.nii.ac.jp
Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD)
and Process Analytical Technology (PAT) | CiNii Research CiNii 国立情報学研究所 学術情報 …